Evidence map›Paper›PMID 27714760›Full record

ArticleBritish journal of pharmacology2016

Role of oxidative stress in oxaliplatin-induced enteric neuropathy and colonic dysmotility in mice.

Rachel M McQuade, Simona E Carbone, Vanesa Stojanovska, Ahmed Rahman, Rachel M Gwynne, Ainsley M Robinson, Craig A Goodman, Joel C Bornstein, Kulmira Nurgali

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rachel M McQuadeCentre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Simona E CarboneCentre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Vanesa StojanovskaCentre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Ahmed RahmanCentre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Rachel M GwynneDepartment of Physiology, Melbourne University, Melbourne, Australia.
Ainsley M RobinsonCentre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Craig A GoodmanCentre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Joel C BornsteinDepartment of Physiology, Melbourne University, Melbourne, Australia.
Kulmira NurgaliCentre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia.
Victoria University · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeOxaliplatin is a platinum-based chemotherapeutic drug used as a first-line therapy for colorectal cancer. However, its use is associated with severe gastrointestinal side-effects resulting in dose limitations and/or cessation of treatment. In this study, we tested whether oxidative stress, caused by chronic oxaliplatin treatment, induces enteric neuronal damage and colonic dysmotility. EXPERIMENTAL APPROACH: Oxaliplatin (3 mg·kg KEY

resultsChronic in vivo oxaliplatin treatment resulted in increased formation of reactive oxygen species (O CONCLUSION AND IMPLICATIONS: Our study is the first to provide evidence that oxidative stress is a key player in enteric neuropathy and colonic dysmotility leading to symptoms of chronic constipation observed in oxaliplatin-treated mice.

Indexed as

AnimalsAntineoplastic AgentsColonIntestinal Pseudo-ObstructionMaleMembrane Potential, MitochondrialMiceMice, Inbred BALB CMitochondriaOrganoplatinum CompoundsOxaliplatinOxidative StressSuperoxidesAntineoplastic AgentsOrganoplatinum CompoundsOxaliplatinSuperoxides

Identifiers

PMID27714760
PMCPMC5120153
OpenAlexW2529206823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.